Back to results
US 2025/0018056 A1Published application
Strategies for knock-ins at c3 safe harbor sites
AssigneeEmendoBio Inc.
InventorsRafi Emmanuel, Michal Golan Mashiach, Joseph Dicken
Life of this patent
Estimating the term…
Abstract
RNA molecules comprising a guide sequence portion having 17-50 contiguous nucleotides in the sequence set forth in any one of SEQ ID NOs: 1-7,046 and compositions, methods, and uses thereof.
Claims28
A method for modifying in a cell an allele of the Complement component 3 (C3) gene, the method comprising
- introducing to the cell a composition comprising:
- at least one CRISPR nuclease or a nucleotide sequence encoding a CRISPR nuclease;
- and
- a RNA molecule comprising a guide sequence portion having 17-50 nucleotides or a nucleotide sequence encoding the same,
- wherein a complex of the CRISPR nuclease and the RNA molecule affects a double strand break in the allele of the C3 gene.
2 more elements
(canceled)
(canceled)
(canceled)
(canceled)
An RNA molecule comprising a guide sequence portion having 17-50 contiguous nucleotides containing nucleotides in the sequence set forth in any one of SEQ ID NOs:
- 1-7,046, or SEQ ID NOs:
- 1-7,046 modified to contain 1, 2, 3, 4, or 5 nucleotide mismatches relative to a fully-complementary C3 target sequence.
(canceled)
(canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.